SOD1 and metabolic dysfunction-associated steatotic liver disease: PHG had no substantial impact on SOD activity (PHG: -12%; NAFLD: -64.5% p < 0.0001; NAFLD+PHG: +15.2%, NAFLD+NAC: -18.2%, NAFLD+ALA:-7.2%) (Figure 2).